Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of plerixafor plus G-CSF versus placebo plus G-CSF in multiple myeloma stem cell mobilization
2006-005320-16Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple myeloma (MM) comparing Plerixafor + G-CSF with Placebo + G-CSF (2 arms). Primary endpoints: Progression-free survival and Overall survival. Started Feb 2007; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2006-005320-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005320-16.